Akebia Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.8M | 1.8M | 2.73 |
| 2025-03-31 | $5.2M | 2.7M | 1.92 |
| 2024-12-31 | $1.9M | 1.0M | 1.90 |
| 2024-09-30 | $641k | 485k | 1.32 |
| 2024-06-30 | $356k | 349k | 1.02 |
| 2024-03-31 | $2.6M | 1.4M | 1.83 |
| 2023-12-31 | $88k | 71k | 1.24 |
| 2023-06-30 | $17k | 18k | 0.92 |
| 2023-03-31 | $38k | 68k | 0.56 |
| 2022-12-31 | $8.8k | 15k | 0.58 |
| 2022-06-30 | $120k | 342k | 0.35 |
| 2022-03-31 | $647k | 901k | 0.72 |
| 2021-12-31 | $4.9M | 2.1M | 2.26 |
| 2021-09-30 | $1.5M | 514k | 2.88 |
| 2021-03-31 | $9.4M | 2.8M | 3.39 |
| 2020-12-31 | $10M | 3.6M | 2.80 |
| 2020-09-30 | $3.6M | 1.5M | 2.51 |
| 2020-06-30 | $16M | 1.1M | 13.58 |
| 2019-12-31 | $4.7M | 748k | 6.32 |
| 2019-09-30 | $1.2M | 308k | 3.92 |
| 2019-06-30 | $1.2M | 255k | 4.84 |
| 2019-03-31 | $3.0M | 361k | 8.19 |
| 2018-12-31 | $2.0M | 369k | 5.53 |
| 2018-09-30 | $1.1M | 124k | 8.83 |
| 2018-06-30 | $3.1M | 308k | 9.98 |
| 2018-03-31 | $7.4M | 782k | 9.53 |
| 2017-12-31 | $10M | 684k | 14.87 |
| 2017-09-30 | $13M | 640k | 19.67 |
| 2017-06-30 | $4.2M | 292k | 14.38 |
| 2017-03-31 | $453k | 49k | 9.19 |
| 2016-12-31 | $507k | 49k | 10.42 |
| 2016-09-30 | $164k | 18k | 9.03 |
| 2016-06-30 | $103k | 14k | 7.47 |
| 2016-03-31 | $128k | 14k | 9.00 |
| 2015-12-31 | $150k | 12k | 12.92 |
| 2015-06-30 | $181k | 18k | 10.27 |